Form 4: Amgen SVP & CCO Nancy A. Grygiel Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Nancy A. Grygiel, SVP & CCO of Amgen Inc., reports the disposition of 524 shares of common stock to cover tax obligations related to vested restricted stock units and shares acquired under the company's 401(k) plan.
Summary
- On March 17, 2025, Nancy A. Grygiel, SVP & CCO of Amgen Inc., reported a change in beneficial ownership of Amgen's common stock.
- 524 shares were disposed of at a price of $313.71 per share to satisfy tax obligations.
- Following the transaction, Grygiel directly owns 8,214 shares of Amgen common stock.
- Grygiel also indirectly owns 102.9274 shares through the company's 401(k) plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate a significant change in the executive's overall holdings or confidence in the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This allows investors to track insider sentiment and potential alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction (disposal of shares) |
| 03/18/2025 | Date of signature |
Keywords
Form 4, Beneficial Ownership, Amgen, AMGN, Grygiel, CCO, Stock, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.